Evidence map›Paper›PMID 42079188›Full record

ArticlebioRxiv : the preprint server for biology2026

Microporous annealed particle scaffolds avoid foreign body response by down regulating complement-fibroblast-macrophage signaling loop.

Colleen A Roosa, Ethan Nicklow, Jeremy Ortmann, Riley Hannan, Jeffrey M Sturek, Daniel Abebayehu, Donald R Griffin

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Colleen A RoosaDepartment of Biomedical Engineering, University of Virginia, Charlottesville, VA.
Ethan NicklowDepartment of Biomedical Engineering, University of Virginia, Charlottesville, VA.
Jeremy OrtmannDepartment of Biomedical Engineering, University of Virginia, Charlottesville, VA.
Riley HannanDepartment of Medicine, Division of Pulmonary and Critical Care, University of Virginia, Charlottesville, VA.
Jeffrey M SturekDepartment of Biomedical Engineering, University of Virginia, Charlottesville, VA.ORCID 0000-0002-2731-3299
Daniel AbebayehuDepartment of Biomedical Engineering, University of Virginia, Charlottesville, VA.ORCID 0000-0002-6837-3028
Donald R GriffinDepartment of Biomedical Engineering, University of Virginia, Charlottesville, VA.ORCID 0000-0002-3458-867X

Funding

Women's Oncology Program - WONP30CA044579 · NCI · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI Dina Gould Halme · 1987 to 2026
$72.1M
Biotechnology Training ProgramT32GM136615 · NIGMS · UNIVERSITY OF VIRGINIA · PI Silvia Salinas Blemker, Kimberly A. Kelly · 2020 to 2026
$3.4M
Engineering Injectable Microporous Hydrogels for Diabetic Wound RepairR01DK126020 · NIDDK · UNIVERSITY OF VIRGINIA · PI GRIFFIN, DONALD RICHIERI · 2021 to 2025
$3.1M
Mechanisms regulating inflammatory fibroblasts in wound healingR35GM160121 · NIGMS · UNIVERSITY OF VIRGINIA · PI ABEBAYEHU, DANIEL · 2025 to 2025
$2.2M
Translating a biostimulatory implant for the long-term treatment of glottic insufficiencyR01DC020998 · NIDCD · UNIVERSITY OF VIRGINIA · PI James J. Daniero, Donald Richieri Griffin · 2023 to 2026
$1.9M
Oxidation-Specific Epitope IgA in Pulmonary FibrosisR01HL179312 · NHLBI · UNIVERSITY OF VIRGINIA · PI Jeffrey Michael Sturek · 2025 to 2026
$1.6M
Improving Biomaterial Implant Tolerance with Damage-Associated Molecular Pathway (DAMP) Molecule AttachmentR21EB028971 · NIBIB · UNIVERSITY OF VIRGINIA · PI EWALD, SARAH E., GRIFFIN, DONALD RICHIERI · 2020 to 2022
$634k
NCI NIH HHS P30 CA044579NHLBI NIH HHS R01 HL179312NIBIB NIH HHS R21 EB028971NIDCD NIH HHS R01 DC020998NIDDK NIH HHS R01 DK126020NIGMS NIH HHS R35 GM160121NIGMS NIH HHS T32 GM136615
6 · The paper itself

Abstract

Biomaterial implantation can trigger a foreign body response (FBR) that impedes tissue-implant integration. To investigate how implant porosity influences this response, we compared the immune response to subcutaneous implants of microporous annealed particle (MAP) scaffolds and nanoporous hydrogels using mass cytometry, single-cell RNA sequencing, and multiplex cytokine assays. MAP scaffolds promoted vascularization and tissue integration, marked by increased endothelial and regulatory T cells, and reduced proinflammatory immune cells and cytokines. In contrast, nanoporous hydrogels demonstrated enrichment of basophils, natural killer cells, and macrophage populations associated with fibrosis. Transcriptomic and proteomic analyses revealed that MAP scaffolds suppressed activation of the complement-fibroblast-macrophage signaling loop, particularly the C5a signaling crosstalk pathway. This was confirmed using C5-deficient mice, where complement-driven cytokine production was significantly reduced only in nanoporous implants. These findings demonstrate that scaffold porosity modulates immune and complement responses, identifying a key mechanism by which MAP scaffolds reduce FBR and improve biomaterial integration.

Indexed as

BiomaterialsComplement PathwayForeign Body ResponseImmune ModulationScaffold Porosity

Identifiers

PMID42079188
PMCPMC13131573

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.